Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ver-A-T1D: Verapamil SR for preservation of beta-cell function in adult type 1 diabetes
2020-000435-45Phase 2Active
- Sponsor
- Medical University of Graz
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing Verapamil SR 360 mg once daily with Placebo once daily (2 arms). Started Nov 2020; status: active.
02
Drugs
verapamil
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2020-000435-45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000435-45.